Relmada Therapeutics RLMD
NASDAQ RLMD
$3.27 -0.02 (-0.61%)
At close: Oct 23, 2026 · 4:00 PM EDT

Relmada Therapeutics (RLMD) Purchase of Investments (2020 - 2026)

Updated

Analysis

Relmada Therapeutics (RLMD) Purchase of Investments (2020 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Purchased (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 307.00 Mn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 919.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 834.00 Mn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 148.00 Mn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 46.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 42.00 Mn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.54 Bn
10 Relmada Therapeutics 348.81 Mn -209.78 Mn - 24.75 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 24.75 Mn
Mar 31, 2026 149.52 Mn
Dec 31, 2025 82.79 Mn
Sep 30, 2025 233,932.00
Jun 30, 2025 321,459.00
Mar 31, 2025 487,916.00
Dec 31, 2024 654,642.00
Sep 30, 2024 3.11 Mn
Jun 30, 2024 1.30 Mn
Mar 31, 2024 7.01 Mn
Dec 31, 2023 33.31 Mn
Sep 30, 2023 11.57 Mn
Jun 30, 2023 10.81 Mn
Mar 31, 2023 34.77 Mn
Dec 31, 2022 8.30 Mn
Sep 30, 2022 5.58 Mn
Jun 30, 2022 7.50 Mn
Mar 31, 2022 25.92 Mn
Dec 31, 2021 140.51 Mn
Sep 30, 2021 25.60 Mn
API Access

Relmada Therapeutics Purchase of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=purchase-of-investments&ticker=RLMD&period=max&api_key=YOUR_API_KEY